Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Alpha-1 in Immunosuppressed Sepsis Patients
NCT07866118Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Randomised, single-blind trial of thymosin alpha 1 in sepsis (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Change From Baseline in Monocyte HLA-DR Expression at Day 7. Started Oct 2026; status: recruiting.
02
Drugs
thymosin alpha 1
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07866118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866118.